Physician profile
David Rivera
NPI 1417246356
$80,393.09
in general payments reported to CMS, 2019-2025
41 companies · $16K in 2025
The $16K reported for 2025 was more than what 92% of Rheumatology providers received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,759 · 2020: $3,999 · 2021: $6,624 · 2022: $19K · 2023: $15K · 2024: $10K · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $24K · Food and Beverage: $12K · Travel and Lodging: $2,601 · Consulting Fee: $1,823 · Education: $118.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $23,625.00 |
| Food and Beverage | $12,457.10 |
| Travel and Lodging | $2,601.24 |
| Consulting Fee | $1,822.50 |
| Education | $118.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $59,112.24 | 2019-2025 | Skyrizi, Rinvoq |
| Amgen INC. | $4,709.56 | 2019-2025 | Tavneos, Enbrel, Evenity |
| Novartis Pharmaceuticals Corporation | $2,603.68 | 2019-2025 | |
| Sobi, INC | $2,239.57 | 2019-2025 | |
| Janssen Biotech, INC. | $1,792.56 | 2019-2025 | Tremfya, Simponi Aria, Simponi |
| Ucb, INC. | $1,707.16 | 2019-2025 | Cimzia, Bimzelx |
| Lilly USA, LLC | $1,316.93 | 2019-2025 | Taltz, Zepbound, Olumiant |
| Pfizer INC. | $1,087.78 | 2019-2025 | |
| Glaxosmithkline, LLC. | $598.61 | 2021-2025 | Benlysta, Nucala |
| E.R. Squibb & Sons, L.L.C. | $543.74 | 2019-2023 | Orencia |
| Mallinckrodt Hospital Products INC. | $508.83 | 2020-2025 | Acthar |
| Aurinia Pharma U.S., INC. | $462.23 | 2021-2025 | Lupkynis |
| Genzyme Corporation | $456.50 | 2019-2025 | |
| Astrazeneca Pharmaceuticals Lp | $428.07 | 2021-2025 | Saphnelo |
| Genentech USA, INC. | $330.88 | 2019-2025 | Actemra |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $330.19 | 2019-2023 | Krystexxa |
| Celgene Corporation | $261.74 | 2019 | |
| Ani Pharmaceuticals, INC. | $185.35 | 2023-2025 | Purified Cortrophin Gel |
| Radius Health, INC. | $181.80 | 2019-2025 | Tymlos |
| Sanofi-Aventis U.S. LLC | $163.62 | 2020-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $150.86 | 2020-2025 | Cyltezo, Spevigo, Ofev |
| Alexion Pharmaceuticals, INC. | $143.07 | 2023-2024 | Strensiq |
| Fresenius Kabi USA, LLC | $125.96 | 2023-2025 | Idacio |
| Greenwich Biosciences, INC. | $119.83 | 2020 | |
| Actelion Pharmaceuticals US, INC. | $116.66 | 2020-2024 | Opsumit, Uptravi |
| Argenx US, INC. | $114.75 | 2025 | Vyvgart |
| Mckesson Specialty Care Distribution, LLC | $107.28 | 2019-2020 | |
| Organon LLC | $87.72 | 2024-2025 | Hadlima |
| Medtronic, INC. | $80.11 | 2024 | Kyphon Express II Kyphopak Tray |
| Sandoz INC. | $52.49 | 2023-2025 | Hyrimoz |
| Almatica Pharma LLC | $41.86 | 2025 | Teriparatide |
| Pacira Therapeutics, INC. | $30.07 | 2019-2020 | |
| Baxter Healthcare | $29.14 | 2025 | Tisseel |
| Kci USA, INC. | $26.20 | 2023 | Prevena, V.A.C. Veraflo |
| Hikma Pharmaceuticals USA | $24.83 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $23.29 | 2022 | |
| Scilex Pharmaceuticals INC. | $21.17 | 2024 | |
| Kyowa Kirin, INC. | $20.21 | 2023 | Crysvita |
| Kiniksa Pharmaceuticals International, Plc | $19.95 | 2024 | Arcalyst |
| Alvogen INC | $18.50 | 2025 | Teriparatide |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $18.10 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Rivera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.